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We have studied the effects of dibromothymoquinone (DBMIB) in various redox activities of the 
succinate-cytochrome c span of the mitochondrial respiratory chain. At concentrations higher than 
50 mol/mol of cytochrome cl the inhibitor produces a bypass of electron transfer on the substrate side 
of the bcl complex, because of its autooxidation capability. This induces an artifactual overestimation of 
the real inhibition titer of the redox activity of this enzyme, which has been found to be 3-6 mol/mol of 
cytochrome ci by following the ubiquinol-cytochrome c reductase activity. This action is reversed by 
addition of excess of sulphydryl compounds like cysteine. 
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1. INTRODUCTION 
The use of specific inhibitors is one of the main 
tools for investigating the mechanism of action of 
the mitochondrial Bcr complex (complex III) [ 1,2]. 
A number of analogs of ubiquinone have been 
found to inhibit the function of this enzyme by 
binding to specific sites close to the iron-sulphur 
center (‘Bieske’ protein) of the complex [2]. 
Among them, 5-n-undecyl-4,7-dioxobenzothiazole 
(UHDBT) [3-51, and n-heptadecyl-mercapto- 
6-hydroxy-5,8-quinoline quinone (HQMHQQ) [6] 
are the most powerful, and have been extensively 
studied. 
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Abbreviations: DBMIB, 2,5-dibromo-3-methyl-diso- 
propylbenzoquinone; DCIP, dichlorophenolindo- 
phenol; EDTA, ethylendiaminotetraacetate; EPR, elec- 
tron paramagnetic resonance; Q,,, 2,3-dimethoxy-S-- 
methylbenzoquinone; Qr, ubiquinone-1; QiHz, QsHz, 
ubiquinol-1 and ubiquinol-3; TTFA, thenoyltrifluoro- 
acetone; UHDBT, 5-n-undecyl-4,7-dioxobenzothiazole 
Another ubiquinone analog which blocks elec- 
tron transfer in the bcr region is dibromothymo- 
quinone (2,5-dibromo-3-methyL64sopropylbenzo- 
quinone, DBMIB), discovered as a potent inhibitor 
of plastoquinol oxidation in chloroplasts [7,8] ac- 
ting at the level of the ba f complex 191. Earlier 
works in the mitochondrial respiratory chain 
[lO-121 have shown that DBMIB inhibits electron 
transfer at concentrations about one order of 
magnitude higher than those required to block the 
b6f complex from chloroplasts [1,9]. Owing to its 
autooxidation properties, it has been considered 
more as a redox mediator than a specific inhibitor 
in the mitochondrial bcl region [ 121. Nevertheless, 
the recent findings [ 13-151 that DBMIB is able to 
stoichiometrically bind and modify the iron- 
sulphur center of the chloroplast b6f complex 
[13- 151, which appears very similar in its physico- 
chemical and functional properties to the analo- 
gous Fe-S center of the mitochondrial bcl comI$ex 
[2,9], have outlined the usefulness of dibromo- 
thymoquinone for clarifying the function of this 
redox center [2]. It has been reported, in fact, that 
DBMIB induces a similar alteration also of the 
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iron-sulphur cluster in the mitochondrial suc- 
cinate-cytochrome c reductase [2]. We have in- 
vestigated the effects of DBMIB in the mitochon- 
drial be1 complex, and found it to be a powerful in- 
hibitor of the enzyme when tested under conditions 
avoiding it to bypass electron transfer in the 
complex. 
2. MATERIALS AND METHGDS 
Beef heart mitochondria were a generous gift 
from Professor D.E. Green (Enzyme Institute, 
Madison). Crude succinate-cytochrome c reduc- 
tase (fraction Sl) was obtained from mitochondria 
by the method in [16l as described in 1171. The bcl 
complex was purified from fraction Sl by the 
method in [ 181. Ubiquinols were prepared as in 
[18]. The electron transfer reaction was assayed at 
room temperature (20°C) as in [19] for the 
succinate-ubiq~none-l-dichlorophenolindophe- 
no1 (DCIP) reductase activity, and as in [20] for 
the succinate and ubiquinol-cytochrome c reduc- 
tase activity. The reduction of DCIP was followed 
at 600-700 nm, and that of cytochrome c at 
550-540 nm in a Sigma Biochem ZWS II dual 
wavelength spectrophotometer equipped with a 
stopped-flow apparatus. Absorbance spectra were 
performed in a Perkin-Elmer 559 spectrophoto- 
meter. The concentration of cytochrome cl was 
measured by the absorbance at 553-540 nm in the 
dithionite-reduced spectra of the mitochondrial 
fractions, with an extinction coefficient of 
20 mM-‘. 
Ubiquinones were kindly offered by Eisai 
(Tokyo). DBMIB was a generous gift from Pro- 
fessor A. Trebst, University of Bochum; it was 
dissolved in ethanol and stored in concentrated 
solution at - 16°C; its concentration was eva- 
luated by the absorbance at 289 nm in ethanol, us- 
ing an extinction coefficient of 14.5 mM_‘. 
3. RESULTS AND DISCUSSION 
The concentration of dibromothymoquinone re- 
quired for h~f-inhibition of the succinate or 
NADH oxidation in intact mitochondrial particles 
is around 25 ,uM [ll], corresponding to about 
100 mol/mol of cytochrome cl. In order to pin- 
point the action of DBMIB, we have titrated its ef- 
fects on the following redox activities in a mito- 
16 
chondrial fraction enriched in the bcl complex 
[17]: succinate-Ql-DCIP reductase, succinate- 
cytochrome c reductase, and ubiquinol-coo- 
chrome c reductase. As shown in table 1, DBMIB 
induces half-inhibition of Q3Hz-cytochrome c 
reductase activity at very low concentrations, and 
of succinate-cytochrome c reductase activity at 
concentrations about one order of magnitude 
higher. 
Moreover the latter activity cannot be complete- 
ly inhibited, and is rather stimulated by high 
DBMIB concentrations in an antimycin-insensitive 
fashion. On the other hand, the rate of DCIP 
reduction is markedly stimulated, and results less 
sensitive to the specific inhibitor TTFA (not 
shown). This effect may be due to the capability of 
DBMIB to accept electrons from the succinate- 
ubiquinone reductase complex, and rapidly 
transfer them to the dye and/or to molecular ox- 
ygen because of its autooxidation properties [12]. 
Such possibility is supported by two experimental 
evidences. Firstly, in detergent-solubilized sub- 
mitochondrial particles, DBMIB can function by 
itself as a substrate replacing exogenous ubiqui- 
none in the succinate-ubiquinone-DCIP reduct- 
ase activity (see also [lo]). Secondly, the rate of 
cytochrome c reduction by succinate becomes 
practically antimycin-insensitive above 100 mol 
DBMIB/mol of cytochrome cl (cf. table 1). This 
non-enzymatic cytochrome c reduction is, how- 
ever, sensitive to superoxide dismutase, and hence 
can be due to a chemical reduction promoted by 
superoxide radicals generated by DBMIB auto- 
oxidation. We have, in fact, observed that dibro- 
mothymoquinone markedly stimulates oxygen 
consumption in the presence of antimycin and 
KCN in fraction S1. Thus DBMIB, at concentra- 
tions higher than 50 mollmol of cytochrome cl, 
may produce a redox bypass at the level of the 
junction between the dehydrogenases and the bcl 
complex, deviating the electrons that flow from 
substrates (and/or from endogenous ubiquinol) to 
oxygen instead of complex III, which is already in- 
hibited. The mechanism of such bypass can be 
described as shown in fig. 1. This scheme accounts 
for the stimulation of succinate oxidation at high 
levels of DBMIB [lo] and for the KCN-insensitive 
oxygen consumption induced by the inhibitor [ 121. 
For a correct evaluation of the specific effects of 
DBMIB on the bcl complex we have to directly 
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Effect of DBMIB on various redox activities of the succinate-cytochrome c span in the mitochondrial fraction Sra 
Addition % Activity 
Succinate-Qr-DCIP Succinate-cytochrome c QsHs-cytochrome c 
(1 mM) (5O/tM) (26pM) (1 mM) (20 PM) (22 PM) (20 PM) 
Turnover no. = 2.4 s-l Turnover no. = 4.5 s-l Turnover no. = 70 s-l 
None 100 100 100 
7 mol DBMIB/mol of bcr 117 87 48 
72 mol DBMIB/mol bcr 260 50 9 
330 mol DBMIB/mol bcr 494 83b 0 
a The enzyme concentrations were 25 nM cytochrome cr for the succinate-DCIP and the succinate-cytochrome c 
reductase activities; and 10 nM for the ubiquinol-cytochrome c reductase activity. The buffer was 50 mM potassium- 
phosphate (pH 7.4) containing 0.5 mM EDTA and 1 mM KCN. The reaction was started by addition of DCIP, 
cytochrome c, and ubiquinol3 for succinate-ubiquinone r ductase, succinate-cytochrome c reductase and 
ubiquinol-cytochrome c reductase activity, respectively 
b The reduction rate of cytochrome c was almost completely antimycin-insensitive, butwas markedly depressed by 
addition of purified superoxide dismutase, to about 40% of the control 
study its ubiquinol-cytochrome c reductase activi- 
ty. The titer for half-inhibition of such activity 
ranges between 3 and 6 mol DBMIB/mol of the 
enzyme in all mitochondrial preparations tested 
(submitochondrial particles, fraction St, and 
isolated bcr complex) and the inhibition shape tend 
to be biphasic (fig.2). These values are comparable 
to that found in the analogous b6f complex from 
chloroplasts [9]. The extent of inhibition does not 
depend on the absolute concentration of DBMIB, 
FUMARATE DBMIB 
Fig.1. Scheme for the possible mechanism of the redox 
bypass operated by DBMIB in the 
succinate-cytochrome c span of the mitochondrial 
respiratory chain. For the sake of clarity, the reduction 
routes of DCIP are omitted from the drawing. The dye 
is normally reduced by ubiquinol, but it could also be 
reduced by either DBMIB or by superoxide radicals, or 
by both. 
but on its ratio to the bcl complex (table 2). The 
potency of the inhibitor increases by increasing the 
number of turnovers made by the enzyme under 
the assay conditions; i.e., the higher the substrates 
concentration, the lower the titer. Furthermore, 
the effect of DBMIB is more pronounced if the bq 
complex is reduced first, as for instance when the 
assay is started by the oxidizing substrate 
1 
% 
actlvlty h 50 0 
0 
50 100 
c 
150 
OBMIB mdlmol C, 
Fig.2. Inhibition by DBMIB of the ubiquinol-1 
(36,uM)-cytochrome c reductase (O---O) and the 
succinate (5 mM)-cytochrome c reductase activity 
(o---o) in fraction Sr. The experimental conditions 
were those employed in table 1, except that in both cases 
the reduction was started with the reducing substrate. 
The uninhibited antimycin-sensitive rates were 126 $-’ 
and 15 s-l for the two redox activities, respectively. 
17 
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Table 2 
Dependence of DBMIB inhibition on the ratio with the 
bcr complex* 
DBMIB bet (nM) DBMIB/bct % residual 
tuM) (mol/mol) ~t~y~n- 
sensitive activity 
0.26 2.9 92 5 
0.26 5.7 46 11 
0.26 9.5 27 20 
’ Different concentrations of isolated bet complex were 
assayed for the ubiquinol-2-(15 PM)-cytochrome c 
(21 pM) reductase activity in 25 mM potassium- 
phosphate buffer, containing 0.5 mM EDTA, pH 7.4. 
The uninhibited reductase rate was 225 s-l 
cytochrome c, after the reducing substrate ubi- 
quinol has been already equilibrated with the en- 
zyme. This behaviour is analogous to that ex- 
hibited by other quinoid inhibitors, such as 
UHDBT [5]. 
The ubiquinol-c~~~orne c reductase rates 
lowered by DBMIB still remain antimycin- 
sensitive. On the other hand, the slow cytochrome 
c reduction by succinate in the presence of 
saturating concentration of antimycin, which is 
about 5-8% of the overall rate, is abolished by low 
concentrations of DBMIB (75% decrease with 
8 mollmol of cytochrome cl). Thus the effect of 
DBMIB appears to be synergistic to that of an- 
timycin in blocking the &i complex. 
The inhibitory action of DBMIB appears very 
similar to that previously reported for Br-Q. [21] 
which can be reversed by addition of sulphydryl 
compounds like cysteine. A similar reversal of the 
DBMIB effects by thiol compounds has been 
found in chloroplasts [22], and could be related to 
the removal of the modification of the iron- 
sulphur cluster induced by the inhibitor in the b6f 
complex [15]. We have therefore thought of in- 
terest to test the effect of thiol compounds on the 
DBMIB inhibition of ubiquinol-cytochrome c 
reductase in the mitochondrial bcl complex. As 
shown in fig.?), the addition of cysteine substantial- 
ly removes the inhibition induced even by high 
concentrations of DBMIB, leaving the reductase 
rate equally ~timycin-sensitive, 
The observed effects of dibromothymoquinone 
appear to be related to specific modifications of 
18 
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Fig.3. Effect of cysteine on the inhibition of DBMIB. 
The assay conditions were those of fig.2 for the 
ubiquinol-1-cytochrome c reductase activity. DBMIB 
was 83 mollmol of cytochrome cl, giving a 83.3% 
inhibition of the reductase rate. Cysteine was 2.5 mM 
and did not stimulate per se the reductase activity, but 
rather produced slightly lower rates with respect to the 
control without any addition. Presented at the bottom of 
the figure is the trace obtained in the presence of 1 FM 
antimycin A, which was identical with or without 
cysteine. 
the mitochondrial bcr complex, as judged by rele- 
vant changes of its absorption spectra in the 
300-400 nm spectral range (M. Degli Esposti, un- 
publish~). Moreover, in coIlaboration with Pro- 
fessor 0. Rotilio of the University of Rome, we 
have verified that in fraction Si the EPR signal at 
gY = 1.90 of the iron-sulphur cluster of the bcl 
complex is dramatically modified by DBMIB con- 
centrations corresponding to those inhibiting the 
redox activity of the enzyme (3-8 mob’mol of 
cytochrome cl) with a spectral shift of the g, value 
of 1.94, resulting almost identical to that reported 
in [ 15,231 in the be f complex. Thus, we can now 
consider dibromothymoquinone as one of the few 
specific and universal inhibitors of the bcl- and bf- 
type redox complexes. 
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